{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:56:19Z","timestamp":1792828579307,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006146","name":"F\u00f6rdergemeinschaft Kinderkrebs-Zentrum Hamburg","doi-asserted-by":"publisher","award":["1"],"award-info":[{"award-number":["1"]}],"id":[{"id":"10.13039\/501100006146","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pituitary neuroendocrine tumors (PitNETs) are classified according to cell lineage, which requires immunohistochemistry for adenohypophyseal hormones and the transcription factors (TFs) PIT1, SF1, and TPIT. According to the current WHO 2022 classification, PitNETs with co-expression of multiple TFs are termed \u201cplurihormonal\u201d. Previously, PIT1\/SF1 co-expression was prevailingly reported in PitNETs, which otherwise correspond to the somatotroph lineage. However, little is known about such tumors and the WHO classification has not recognized their significance. We compiled an in-house case series of 100 tumors, previously diagnosed as somatotroph PitNETs. Following TF staining, histopathological features associated with PIT1\/SF1 co-expression were assessed. Integration of in-house and publicly available sample data allowed for a meta-analysis of SF1-associated clinicopathological and molecular features across a total of 270 somatotroph PitNETs. The majority (74%, 52\/70) of our densely granulated somatotroph PitNETs (DGST) unequivocally co-expressed PIT1 and SF1 (DGST-PIT1\/SF1). None (0%, 0\/30) of our sparsely granulated somatotroph PitNETs (SGST) stained positive for SF1 (SGST-PIT1). Among DGST, PIT1\/SF1 co-expression was significantly associated with scarce FSH\/LH expression and fewer fibrous bodies compared to DGST-PIT1. Integrated molecular analyses including publicly available samples confirmed that DGST-PIT1\/SF1, DGST-PIT1 and SGST-PIT1 represent distinct tumor subtypes. Clinicopathological meta-analyses indicated that DGST-PIT1 respond more favorably towards treatment with somatostatin analogs compared to DGST-PIT1\/SF1, while both these subtypes show an overall less aggressive clinical course than SGST-PIT1. In this study, we spotlight that DGST with co-expression of PIT1 and SF1 represent a common, yet underrecognized, distinct PitNET subtype. Our study questions the rationale of generally classifying such tumors as \u201cplurihormonal\u201d, and calls for a refinement of the WHO classification. We propose the term \u201csomatogonadotroph PitNET\u201d.<\/jats:p>","DOI":"10.1007\/s00401-024-02686-1","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T18:01:56Z","timestamp":1705428116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Pituitary neuroendocrine tumors with PIT1\/SF1 co-expression show distinct clinicopathological and molecular features"],"prefix":"10.1007","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9769-7080","authenticated-orcid":false,"given":"Matthias","family":"Dottermusch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Ryba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz L.","family":"Ricklefs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Flitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Glatzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Saeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia E.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8731-1121","authenticated-orcid":false,"given":"Ulrich","family":"Sch\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"2686_CR1","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD et al (2014) Minfi: a flexible and comprehensive bioconductor package for the analysis of infinium DNA methylation microarrays. Bioinformatics 30:1363\u20131369. https:\/\/doi.org\/10.1093\/bioinformatics\/btu049","journal-title":"Bioinformatics"},{"key":"2686_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/S12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol 33:6\u201326. https:\/\/doi.org\/10.1007\/S12022-022-09703-7","journal-title":"Endocr Pathol"},{"key":"2686_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/S12022-023-09777-X","author":"SL Asa","year":"2023","unstructured":"Asa SL, Mete O, Riddle ND, Perry A (2023) Multilineage pituitary neuroendocrine tumors (PitNETs) expressing PIT1 and SF1. Endocr Pathol. https:\/\/doi.org\/10.1007\/S12022-023-09777-X","journal-title":"Endocr Pathol"},{"key":"2686_CR4","doi-asserted-by":"publisher","first-page":"20007","DOI":"10.1073\/PNAS.0710052104\/SUPPL_FILE\/IMAGE1804.GIF","volume":"104","author":"R Beroukhim","year":"2007","unstructured":"Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D et al (2007) Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci USA 104:20007\u201320012. https:\/\/doi.org\/10.1073\/PNAS.0710052104\/SUPPL_FILE\/IMAGE1804.GIF","journal-title":"Proc Natl Acad Sci USA"},{"key":"2686_CR5","doi-asserted-by":"publisher","first-page":"6290","DOI":"10.1210\/JC.2005-0998","volume":"90","author":"S Bhayana","year":"2005","unstructured":"Bhayana S, Booth GL, Asa SL, Kovacs K, Ezzat S (2005) The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly. J Clin Endocrinol Metab 90:6290\u20136295. https:\/\/doi.org\/10.1210\/JC.2005-0998","journal-title":"J Clin Endocrinol Metab"},{"key":"2686_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469\u2013474. https:\/\/doi.org\/10.1038\/nature26000","journal-title":"Nature"},{"key":"2686_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/NAN.12870","volume":"49","author":"M Dottermusch","year":"2023","unstructured":"Dottermusch M, Sch\u00fcller U, Hagel C, Saeger W (2023) Unveiling the identities of null cell tumours: epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour\/adenoma classification. Neuropathol Appl Neurobiol 49:e12870. https:\/\/doi.org\/10.1111\/NAN.12870","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2686_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/S11102-015-0662-5\/FIGURES\/3","volume":"18","author":"ZA Efstathiadou","year":"2015","unstructured":"Efstathiadou ZA, Bargiota A, Chrisoulidou A, Kanakis G, Papanastasiou L, Theodoropoulou A et al (2015) Impact of gsp mutations in somatotroph pituitary adenomas on growth hormone response to somatostatin analogs: a meta-analysis. Pituitary 18:861\u2013867. https:\/\/doi.org\/10.1007\/S11102-015-0662-5\/FIGURES\/3","journal-title":"Pituitary"},{"key":"2686_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000178983","volume":"10","author":"PU Heitz","year":"1979","unstructured":"Heitz PU (1979) Multihormonal pituitary adenomas. Horm Res 10:1\u201313. https:\/\/doi.org\/10.1159\/000178983","journal-title":"Horm Res"},{"key":"2686_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1530\/EJE-15-0832","volume":"174","author":"D Iacovazzo","year":"2016","unstructured":"Iacovazzo D, Carlsen E, Lugli F, Chiloiro S, Piacentini S, Bianchi A et al (2016) Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. Eur J Endocrinol 174:241\u2013250. https:\/\/doi.org\/10.1530\/EJE-15-0832","journal-title":"Eur J Endocrinol"},{"key":"2686_CR11","doi-asserted-by":"publisher","DOI":"10.1159\/000533692","author":"P Kober","year":"2023","unstructured":"Kober P, Rymuza J, Baluszek S, Maksymowicz M, Nyc A, Mossakowska BJ et al (2023) DNA methylation pattern in somatotroph pituitary neuroendocrine tumors. Neuroendocrinology. https:\/\/doi.org\/10.1159\/000533692","journal-title":"Neuroendocrinology"},{"key":"2686_CR12","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1210\/JCEM.86.9.7819","volume":"86","author":"J Kreutzer","year":"2001","unstructured":"Kreutzer J, Vance ML, Lopes MBS, Laws ER (2001) Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab 86:4072\u20134077. https:\/\/doi.org\/10.1210\/JCEM.86.9.7819","journal-title":"J Clin Endocrinol Metab"},{"key":"2686_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/EJE-12-0864","volume":"168","author":"S Larkin","year":"2013","unstructured":"Larkin S, Reddy R, Karavitaki N, Cudlip S, Wass J, Ansorge O (2013) Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-na\u00efve patients with somatotroph adenomas. Eur J Endocrinol 168:491\u2013499. https:\/\/doi.org\/10.1530\/EJE-12-0864","journal-title":"Eur J Endocrinol"},{"key":"2686_CR14","first-page":"163","volume":"20","author":"PR Mazal","year":"2001","unstructured":"Mazal PR, Czech T, Sedivy R, Aichholzer M, Wanschitz J, Klupp N et al (2001) Prognostic relevance of intracytoplasmic cytokeratin pattern, hormone expression profile, and cell proliferation in pituitary adenomas of akromegalic patients. Clin Neuropathol 20:163\u2013171","journal-title":"Clin Neuropathol"},{"key":"2686_CR15","doi-asserted-by":"publisher","unstructured":"McInnes L, Healy J, Melville J (2018) UMAP: uniform manifold approximation and projection for dimension reduction. https:\/\/doi.org\/10.48550\/arxiv.1802.03426","DOI":"10.48550\/arxiv.1802.03426"},{"key":"2686_CR16","first-page":"900","volume-title":"Modern Pathology","author":"O Mete","year":"2018","unstructured":"Mete O, Cintosun A, Pressman I, Asa SL (2018) Epidemiology and biomarker profile of pituitary adenohypophysial tumors. Modern Pathology. Nature Publishing Group, pp 900\u2013909"},{"key":"2686_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou M, Villa C, Armignacco R, Jouinot A, Raffin-Sanson ML, Septier A et al (2020) Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 37:123-134.e5. https:\/\/doi.org\/10.1016\/j.ccell.2019.11.002","journal-title":"Cancer Cell"},{"key":"2686_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/S12022-008-9029-Z","volume":"19","author":"A Obari","year":"2008","unstructured":"Obari A, Sano T, Ohyama K, Kudo E, Qian ZR, Yoneda A et al (2008) Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form. Endocr Pathol 19:82\u201391. https:\/\/doi.org\/10.1007\/S12022-008-9029-Z","journal-title":"Endocr Pathol"},{"key":"2686_CR19","unstructured":"R Core Team (2020) R: a language and environment for statistical computing"},{"key":"2686_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS11233846","author":"J Rymuza","year":"2022","unstructured":"Rymuza J, Kober P, Rusetska N, Mossakowska BJ, Maksymowicz M, Nyc A et al (2022) Transcriptomic classification of pituitary neuroendocrine tumors causing acromegaly. Cells. https:\/\/doi.org\/10.3390\/CELLS11233846","journal-title":"Cells"},{"key":"2686_CR21","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1158\/1078-0432.CCR-17-2206","volume":"24","author":"MP Salomon","year":"2018","unstructured":"Salomon MP, Wang X, Marzese DM, Hsu SC, Nelson N, Zhang X et al (2018) The epigenomic landscape of pituitary adenomas reveals specific alterations and differentiates among acromegaly, Cushing\u2019s disease and endocrine-inactive subtypes. Clin Cancer Res 24:4126\u20134136. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-2206","journal-title":"Clin Cancer Res"},{"key":"2686_CR22","first-page":"69","volume":"3","author":"BW Scheithauer","year":"1986","unstructured":"Scheithauer BW, Horvath E, Kovacs K, Laws ER, Randall RV, Ryan N (1986) Plurihormonal pituitary adenomas. Semin Diagn Pathol 3:69\u201382","journal-title":"Semin Diagn Pathol"},{"key":"2686_CR23","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1210\/CLINEM\/DGAC703","volume":"108","author":"RMP da Silva-J\u00fanior","year":"2023","unstructured":"da Silva-J\u00fanior RMP, Bueno AC, Martins CS, Coelli-Lacchini F, Ozaki JGO, de Almeida-E-Silva DC et al (2023) Integrating methylome and transcriptome signatures expands the molecular classification of the pituitary tumors. J Clin Endocrinol Metab 108:1452\u20131463. https:\/\/doi.org\/10.1210\/CLINEM\/DGAC703","journal-title":"J Clin Endocrinol Metab"},{"key":"2686_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/J.HUMPATH.2020.12.001","volume":"110","author":"S Silva-Ortega","year":"2021","unstructured":"Silva-Ortega S, Garc\u00eda-Martinez A, Niveiro de Jaime M, Torregrosa ME, Abarca J, Monjas I et al (2021) Proposal of a clinically relevant working classification of pituitary neuroendocrine tumors based on pituitary transcription factors. Hum Pathol 110:20\u201330. https:\/\/doi.org\/10.1016\/J.HUMPATH.2020.12.001","journal-title":"Hum Pathol"},{"key":"2686_CR25","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/BIOINFORMATICS\/BTZ632","volume":"36","author":"V Da Silva","year":"2020","unstructured":"Da Silva V, Ramos M, Groenen M, Crooijmans R, Johansson A, Regitano L et al (2020) CNVRanger: association analysis of CNVs with gene expression and quantitative phenotypes. Bioinformatics 36:972\u2013973. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTZ632","journal-title":"Bioinformatics"},{"key":"2686_CR26","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1093\/BIOINFORMATICS\/BTW325","volume":"32","author":"ZL Skidmore","year":"2016","unstructured":"Skidmore ZL, Wagner AH, Lesurf R, Campbell KM, Kunisaki J, Griffith OL et al (2016) GenVisR: genomic visualizations in R. Bioinformatics 32:3012\u20133014. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTW325","journal-title":"Bioinformatics"},{"key":"2686_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/S11102-020-01096-2","volume":"24","author":"AA Swanson","year":"2021","unstructured":"Swanson AA, Erickson D, Donegan DM, Jenkins SM, Van Gompel JJ, Atkinson JLD et al (2021) Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly. Pituitary 24:192\u2013206. https:\/\/doi.org\/10.1007\/S11102-020-01096-2","journal-title":"Pituitary"},{"key":"2686_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-76555-8","volume":"10","author":"K Taniguchi-Ponciano","year":"2020","unstructured":"Taniguchi-Ponciano K, Andonegui-Elguera S, Pe\u00f1a-Mart\u00ednez E, Silva-Rom\u00e1n G, Vela-Pati\u00f1o S, Gomez-Apo E et al (2020) Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors. Sci Rep 10:1\u201311. https:\/\/doi.org\/10.1038\/s41598-020-76555-8","journal-title":"Sci Rep"},{"key":"2686_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/S40478-021-01284-6","author":"A Tebani","year":"2021","unstructured":"Tebani A, Jotanovic J, Hekmati N, Sivertsson \u00c5, Gudjonsson O, Ed\u00e9n Engstr\u00f6m B et al (2021) Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/S40478-021-01284-6","journal-title":"Acta Neuropathol Commun"},{"key":"2686_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/S00428-023-03642-2","author":"S Uccella","year":"2023","unstructured":"Uccella S, Leoni E, Kaiser S, Maragliano R, Valerio A, Libera L et al (2023) Heterogeneity of TPIT expression in ACTH-secreting extra-pituitary neuroendocrine tumors (NETs) supports the existence of different cellular programs in pancreatic and pulmonary NETs. Virchows Arch. https:\/\/doi.org\/10.1007\/S00428-023-03642-2","journal-title":"Virchows Arch"},{"key":"2686_CR31","unstructured":"WHO Classification of Tumours Editorial Board. Endocrine and Neuroendocrine tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2022 [cited 27 Nov 2023]. (WHO classification of tumours series, 5th ed.; vol. 8). https:\/\/tumourclassification.iarc.who.int\/chapters\/36"},{"key":"2686_CR32","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/BIOINFORMATICS\/BTQ170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN (2010) ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26:1572\u20131573. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTQ170","journal-title":"Bioinformatics"},{"issue":"5","key":"2686_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-022-04272-1","volume":"51","author":"A Yamato","year":"2022","unstructured":"Yamato A, Nagano H, Gao Y, Matsuda T, Hashimoto N, Nakayama A et al (2022) Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas\/somatotroph pituitary neuroendocrine tumors. Commun Biol 51(5):1\u201314. https:\/\/doi.org\/10.1038\/s42003-022-04272-1","journal-title":"Commun Biol"},{"key":"2686_CR34","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1530\/EJE.0.1340720","volume":"134","author":"I Yang","year":"1996","unstructured":"Yang I, Park S, Ryu M, Woo J, Kim S, Kim J et al (1996) Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients. Eur J Endocrinol 134:720\u2013726. https:\/\/doi.org\/10.1530\/EJE.0.1340720","journal-title":"Eur J Endocrinol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-024-02686-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-024-02686-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-024-02686-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T18:06:20Z","timestamp":1705428380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-024-02686-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2686"],"URL":"https:\/\/doi.org\/10.1007\/s00401-024-02686-1","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"assertion":[{"value":"28 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The use of all tissue specimens for research upon anonymization was in accordance with local and national ethical standards and with the 1964 Helsinki declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"16"}}